Objectives: This study aimed to explore sex-related differences in mild cognitive patients due to Alzheimer's Disease (MCI-AD) and due to Dementia Lewy Body (MCI-DLB). Materials and Methods: This observational study included patients with MCI-AD and MCI- DLB from Policlinico Tor Vergata and Policlinico Umberto I. Patients wore an actigraph on the non-dominant wrist for 7 days and completed a sleep diary. All patients underwent neuropsychological evaluation (including Mini-Mental State Examination MMSE) and completed a battery of self-report questionnaires to assess excessive daytime sleepiness (Epworth Sleepiness Scale, ESS) and perceived sleep quality (Pittsburgh Sleep Quality Index, PSQI). All patients were compared with a control group without sleep disorders or neurodegenerative or psychiatric conditions. As data were not normally distributed, group comparisons and sex differences within each group were analysed using the Kruskal-Wallis test and Mann–Whitney U test. Results: The study included 14 MCI-AD patients (57.1% male; mean age 72.07 ± 6.33 years, MMSE 23.85 ± 4.24), 22 MCI-DLB patients (59.1% male; mean age 79.59 ± 7.62 years, MMSE 26.00 ± 2.26), and 16 controls (56.3% male; mean age 67.63 ± 6.34 years, MMSE 29.66 ± 0.77). Group comparisons showed higher PSQI scores in MCI-DLB patients compared to controls (p=0.001), greater nocturnal wake time (p=0.033) in MCI-AD compared to MCI-DLB, and both a lower day–night activity ratio (p=0.001) and higher fragmentation index (p=0.021) in MCI-AD compared to controls. Among MCI-AD patients, females showed significantly greater wake time during the night compared to males (p = 0.043). In the MCI-DLB group, females exhibited higher average activity during the most active 10-hour period (M10; p = 0.02), higher relative amplitude (RA; p = 0.06), and lower inter daily variability (IV; p = 0.09) than males MCI-DLB. Among controls, females also showed higher M10 values (p = 0.42) and significantly lower RA (p = 0.042) than males. No significant sex differences were observed in ESS scores in either group. However, among MCI-DLB patients, females reported significantly poorer sleep quality on the PSQI compared to males. Discussion: Findings suggest sex-related differences in rest–activity patterns and sleep fragmentation in both MCI-AD and MCI-DLB. Females with MCI-AD showed greater nocturnal wakefulness, possibly reflecting more fragmented sleep. In contrast, MCI-DLB females displayed more stable circadian activity and reported poorer subjective sleep quality. These patterns may reflect both neurodegenerative pathology and sex-specific factors. Conclusions: Sex-related differences in sleep and circadian patterns are present in MCI-AD and MCI-DLB. These preliminary findings highlight the need to consider sex in the clinical assessment of neurodegenerative conditions.

Sex Differences in Sleep and Circadian Activity Patterns in MCI due to Alzheimer’s and Lewy Body Disease / Avvento, Francesca; Fernandes, Mariana; Bertini, Beatrice; Zazzaro, Giulia; D’Antonio, Fabrizia; Biagio Mercuri, Nicola; Liguori, Claudio. - (2025). ( XX Congresso SINdem Rome; Italy ).

Sex Differences in Sleep and Circadian Activity Patterns in MCI due to Alzheimer’s and Lewy Body Disease

Francesca Avvento;Giulia Zazzaro;Fabrizia D’Antonio;Claudio Liguori
2025

Abstract

Objectives: This study aimed to explore sex-related differences in mild cognitive patients due to Alzheimer's Disease (MCI-AD) and due to Dementia Lewy Body (MCI-DLB). Materials and Methods: This observational study included patients with MCI-AD and MCI- DLB from Policlinico Tor Vergata and Policlinico Umberto I. Patients wore an actigraph on the non-dominant wrist for 7 days and completed a sleep diary. All patients underwent neuropsychological evaluation (including Mini-Mental State Examination MMSE) and completed a battery of self-report questionnaires to assess excessive daytime sleepiness (Epworth Sleepiness Scale, ESS) and perceived sleep quality (Pittsburgh Sleep Quality Index, PSQI). All patients were compared with a control group without sleep disorders or neurodegenerative or psychiatric conditions. As data were not normally distributed, group comparisons and sex differences within each group were analysed using the Kruskal-Wallis test and Mann–Whitney U test. Results: The study included 14 MCI-AD patients (57.1% male; mean age 72.07 ± 6.33 years, MMSE 23.85 ± 4.24), 22 MCI-DLB patients (59.1% male; mean age 79.59 ± 7.62 years, MMSE 26.00 ± 2.26), and 16 controls (56.3% male; mean age 67.63 ± 6.34 years, MMSE 29.66 ± 0.77). Group comparisons showed higher PSQI scores in MCI-DLB patients compared to controls (p=0.001), greater nocturnal wake time (p=0.033) in MCI-AD compared to MCI-DLB, and both a lower day–night activity ratio (p=0.001) and higher fragmentation index (p=0.021) in MCI-AD compared to controls. Among MCI-AD patients, females showed significantly greater wake time during the night compared to males (p = 0.043). In the MCI-DLB group, females exhibited higher average activity during the most active 10-hour period (M10; p = 0.02), higher relative amplitude (RA; p = 0.06), and lower inter daily variability (IV; p = 0.09) than males MCI-DLB. Among controls, females also showed higher M10 values (p = 0.42) and significantly lower RA (p = 0.042) than males. No significant sex differences were observed in ESS scores in either group. However, among MCI-DLB patients, females reported significantly poorer sleep quality on the PSQI compared to males. Discussion: Findings suggest sex-related differences in rest–activity patterns and sleep fragmentation in both MCI-AD and MCI-DLB. Females with MCI-AD showed greater nocturnal wakefulness, possibly reflecting more fragmented sleep. In contrast, MCI-DLB females displayed more stable circadian activity and reported poorer subjective sleep quality. These patterns may reflect both neurodegenerative pathology and sex-specific factors. Conclusions: Sex-related differences in sleep and circadian patterns are present in MCI-AD and MCI-DLB. These preliminary findings highlight the need to consider sex in the clinical assessment of neurodegenerative conditions.
2025
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1760945
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact